Search

Croda International PLC

Open

2,797 -1.76

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2767

Max

2847

Schlüsselkennzahlen

By Trading Economics

Einkommen

-18M

61M

Verkäufe

44M

856M

KGV

Branchendurchschnitt

19.11

85.308

EPS

0.722

Dividendenrendite

3.69

Gewinnspanne

7.151

Angestellte

6,027

EBITDA

-21M

168M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+9.46% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

3.69%

3.17%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

677M

4.2B

Vorheriger Eröffnungskurs

2798.76

Vorheriger Schlusskurs

2797

Croda International PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Nov. 2025, 21:44 UTC

Ergebnisse

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3. Nov. 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3. Nov. 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3. Nov. 2025, 23:28 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3. Nov. 2025, 23:24 UTC

Ergebnisse

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. Nov. 2025, 23:14 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

3. Nov. 2025, 23:14 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3. Nov. 2025, 23:12 UTC

Ergebnisse

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3. Nov. 2025, 23:06 UTC

Market Talk
Ergebnisse

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3. Nov. 2025, 22:36 UTC

Market Talk
Ergebnisse

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3. Nov. 2025, 22:31 UTC

Ergebnisse

Franco-Nevada 3Q EPS $1.49 >FNV

3. Nov. 2025, 22:31 UTC

Ergebnisse

Franco-Nevada 3Q Rev $487.7M >FNV

3. Nov. 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3. Nov. 2025, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks Agrees to Sell Stake in China Business -- WSJ

3. Nov. 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3. Nov. 2025, 21:54 UTC

Market Talk
Ergebnisse

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3. Nov. 2025, 21:54 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

3. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. Nov. 2025, 21:49 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3. Nov. 2025, 21:40 UTC

Ergebnisse

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3. Nov. 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3. Nov. 2025, 21:19 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3. Nov. 2025, 21:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3. Nov. 2025, 21:11 UTC

Ergebnisse

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3. Nov. 2025, 21:07 UTC

Ergebnisse

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3. Nov. 2025, 21:05 UTC

Ergebnisse

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3. Nov. 2025, 21:05 UTC

Ergebnisse

Palantir Technologies 3Q Net $475.6M >PLTR

Croda International PLC Prognose

Kursziel

By TipRanks

9.46% Vorteil

12-Monats-Prognose

Durchschnitt 3,160 GBX  9.46%

Hoch 4,450 GBX

Tief 2,400 GBX

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Croda International PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

9 ratings

4

Buy

3

Halten

2

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Croda International PLC

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
help-icon Live chat